VHL and cancer: Despite an increase in HIF stabilization and glycolytic transcript signatures both in vitro and in vivo, the fractionated Vhl-KO CD45– cells isolated from tumors, which predominately consist of cancer cells, did not functionally consume more glucose in our models as compared with Vhl WT CD45– fractions.